The past, present, and future of xenotransplantation

Yonsei Medical Journal

Volumn 45, Issue 6, 2004, Pages 1017-1024

  Ahn, Curie ^a,b   Kim, Jae Young ^b   Lee, Byeong Chun ^a   Kang, Sung Keun ^a   Lee, Jeong Ryul ^a   Hwang, Woo Suk ^a  

^a Seoul National University   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE;

ALLOTRANSPLANTATION; CELL TRANSPLANTATION; CELLULAR IMMUNITY; COMPLEMENT ACTIVATION; DISEASE CLASSIFICATION; DISEASE TRANSMISSION; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; INTERMETHOD COMPARISON; MOLECULAR MECHANICS; NONHUMAN; ORGAN DONOR; REVIEW; SPECIES DIFFERENCE; SURVIVAL RATE; XENOTRANSPLANTATION;

EID: 12344306387     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2004.45.6.1017     Document Type: Review

References (47)

1. Taniguchi S, Cooper DKC. Clinical xenotransplantation: past, present and future. Ann R Coll Surg Engl 1997; 79:13-9.
2. Auchincloss H Jr. Xenogeneic transplantation. Transplantation 1988;46:1-20.
3. Reemtsma K, McCrackern BH, Schlegel JU, Pearl MA, Pearl CW, Dewitt CW, et al. Renal heterotransplantation in man. Ann Surg 1964;100:384-410.
4. Hardy JD, Kurrus FD, Chavez CM, Neely WA, Eraslan S, Turner MD, Fabian LW, Labecki TD. Heart transplantation in man. Developmental studies and report of a case. JAMA 1964:188:1132-40.
5. Hardy JD, Chavez CM. The first heart transplantation in man. Developmental animal investigations with analysis of the 1964 case in the light of current clinical experience. Am J Cardiol 1968;22:772-81.
6. Bailey LL, Nehlsen-Cannarella SL, Concepcion W, Jolley WB. Baboon-to-human cardiac xenotransplantation in a neonate. JAMA 1985;254:3321-9.
7. Walpoth BH, Nehlsen-Cannarella SL, Bailey LL. Xeno-transplantation: extended indications for pediatric cardiac transplantation. Transplant Proc 1986;18:43.
8. Kissmeyer-Nielson F, Olsen S, Peterson VP, Fjeldborg O. Hyperacute rejection of kidney allografts, associated with pre-existing Immoral antibodies against donor cells. Lancet 1966;2:662-5.
9. Douglas JD. Suitability and availability of chimpanzees as organ donors for man. Transplant Proc 1970;2:539.
10. Woodruff M. Summary. Transplant Proc 1970;2:557.
11. Kobayashi T, Cooper DKC. Anti-Gal, α-Gal epitopes and xenotransplantation. In: Galili U, Avila JL, editors. α-Gal and Anti-Gal: α-1,3-Galactosyltransferase. α-Gal Eiptopes and the Natural Anti-Gal antibody (Subcellular Biochemistry Series), vol. 32. New York, London: Kluwer Aacademic/Plenum; 1999. p.229-57.
12. Pruitt SK, Baldwin III WM, Barth RN, Sanfilippo F. The effect of xenoreactive antibody and B cell depletion on hyperacute rejection of guinea pig-to rat cardiac xenografts. Transplantaion 1993;56:1318-24.
13. Atkinson JP, Odlesby TJ, White OJG, Adams EA, Liszewski MK. Separation of self from non-self in the complement system. A role for membrane cofactor protein and decay accelerating factor. Clin Exp Immunol 1991;86:27-30.
14. Lachman P. The control of homologous lysis. Immunol Today 1991;12:312-5.
15. Fodor WL, Willians BL, Matis LA, Madri JA, Rollins SA, Knight JW, et al. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneicn hyperacute organ rejection. Proc Natl Acad Sci USA 1994;91:11153-7.
16. McCurry KR, Kooyman DL, Alvarado CG, Cotterell AH, Martin MJ, Logan JS, et al. Human complement regulatory protein protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1995;1:423-7.
17. Leventhal JR, John R, Fryer JP, Witson JC, Derlich JM, Remiszewski J, et al. Removal of baboon and human antiporcine IgG and IgM natural antibodies by immunoadsorption: Results of in vitro and in vivo studies. Transplantation 1995;59:294-300.
18. Rydberg L, Hallberg E, Bjorck S, Cairns TDH, Groth C-G. Studies on the removal of anti-pig xenoantibodies in the human by plasmapheresis/immunoadsorption. Xenotransplantation 1995;2:253-63.
19. Taniguchi S, Neethling FA, Korchargina EY, Bovin N, Ye Y, Kobayashi T, et al. In vivo immunoadsorption of antipig antibodies in baboons using a specific Gal α1,3 Gal column. Transplantation 1996;62:1379-84.
20. Latinne D, Soares M, Havaux X, Cormont F, Lesnikoski B, Bach FH, et al. Depletion of IgM xenoreactive natural antibodies by injection of anti-mu monoclonal antibodies. Immunol Rev 1994;141:95-125.
21. Simon PM, Neethling FA, Taniguchi S, Goode PL, Zopf D, Hancock WW, et al. Intravenous infusion of Gal alpha 1-3 Gal oligosaccarides inbaboone delays hyperacute rejection of porcine heart xenograft. Transplantation 1998;65:346-53.
22. Sharma A, Okare J, Birch P, McClellan SB, Martin MJ, Platt JL, et al. Reduction in the level of Gal (alpha 1, 3) Gal in transgenic mice and pigs by the expression of an alpha (1,2) fucosyltransferase. Proc Natl Acad Sci USA 1996;93:7190-5.
23. Kobayashi T, Neethling FA, Koren E, Taniguchi S, Ye Y, Niekrasz M, et al. In vitro an in vivo investigation of anticomplement agents FUT-175 and K76COOH, in the prevention of hyperacute rejection following discordant xenotransplantion in a non-human primate model. Transplant Proc 1996;28:604.
24. Leventhal JR, Dalmasso AP, Cromwell JW, Platt JL, Manivel CJ, Bolman RM 3rd, et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993;55:857.
25. Pruitt SK, Bollinger RR, Colline BH, Marsh HC Jr, Levin JL, Rudolph AR, et al. Effect of continuous complement inhibition using soluble complement receptor type 1 on survival of pig-to-primate cardiac xenografts. Transplantation 1997;63:910-2.
26. Rollins SA, Matis LA, Springhorm JP, Setter E, Wolff DW. Monoclonal antibodies directed against human C5 and C8 flock complement-mediated damage of xenogeneic cells and organs. Transplantation 1995;60:1284-94.
27. Platt JL, Lin SS, McGregor CG. Acute vascular rejection. Xenotransplantation 1998;5:169-75.
28. Millan MT, Geczy C, Stuhlmeier KM, Goodman DJ, Feran C, Bach FH. Human monocytes activate porcine endothelial cells, resulting in increase E-selectin, interleukin-8, monocyte chemotactic protein-1 and plasminogen activator inhibitor-type I expression. Transplantation 1997;63:421-9.
29. Grimm S, Bauer MK, Baeuerle PA, Schulze-Osthoff K. Bcl-2 down-regulates the activity of transcription factor NF-κB induce upon apoptosis. J Cell Biol 1996;134:13-23.
30. Wrighton CJ, Kopp CW, McShea A, Vetr H, Bach FH. High-level expression of functional human thrombomodulin in cultured porcine aortic endothelial cells. Transplant Proc 1995;27:288-9.
31. Bach FH. Xenotransplantation: Problems and prospects. Annu Rev Med 1998;49:301-10.
32. Lin SS, Hanaway MJ, Gonzalez-Stawinski GV, Lau CL, Parker W, Davis RD, et al. The role of anti-Gal α1-3 Gal antibodies in acute vascular rejection and accommodation of xenografts. Transplantation 2000;70:1667-74.
33. Lin Y, Vandeputle M, Waer M. Accommodation and T-independent B cell tolerance in rats with long trem surviving hamster heart xenografts. J Immunol 1998; 160:369-75.
34. Sachs DH, Sablinski T. Tolerance across discordant xenogeneic barriers. Xenotransplantation 1995;2:234-9.
35. Maher SE, Karmann K, Min W, Hughes CC, Pober JS, Bathwell AL. Pocine endothelial CD86 is a major costimulator of xenogeneic cells human T cells: cloning, sequencing and functional expression in human endothelial cells. J Immunol 1996;157:3838.
36. Hammer C. Evolution: its complexity and inpact on xenotransplantation. In: Cooper DKC, Kemp E, Platt JL, White DJG, editors. 2nd ed. Heidelberg: Spinger; 1997. p.716-35.
37. Patience C, Takeuchi Y, Weiss RA. Infection of human cells by an endogenous retrovirus of pigs. Nat Med 1997;3:282-6.
38. Hyun S, Lee G, Kim D, Kim H, Lee S, Nam D, et al. Production of nuclear transfer-derived piglets using porcine fetal fibroblasts transfected with the enhanced green fluorescent protein. Biol Reprod 2003;69:1060-8.
39. Phelps CJ, Koike C, Vaught TD, Boone J, Wells KD, Chen SH, et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003;299:411-4.
40. Bach FH. Genetic engineering as an approach to xenotransplantation. World J Surg 1997;913-6.
41. Platt JL. Immunobiology of xenotransplantation. Transplant Int 2000;13:7-10.
42. Cooper DKC. Xenotransplantation-will it happen? J Circ Support 1998;1:3-12.
43. Groth CG, Tibell A, Wennberg L, Bennet W, Lundgren T, Rydgard KJ, et al. Clinical aspect and perspectives in islet cell xenotransplantation. J Hepatobiliary Pancreat Surg 2000;7:364-9.
44. Hancock WW. The past, present and future of renal transplantation. Kidney Int 1997;51:932-44.
45. Lanza RP, Cooper DKC, Chick WL. Xenotransplantation. Scientific America; 1997. p.54-9.
46. Logan JS. Prospects for xenotransplantation. Curr Opin Immunol 2000;12:563-8.
47. Platt JL, Lin SS. The future promises of xenotransplantation. Ann NY Acad Sci 1998;862:5-18.